Pharbetol
- Product NDC
- 16103-376
- 11-digit product format
- 161030376
- Labeler code
- 16103
- Product ID
- 16103-376_008cf9fd-c19d-4e32-8386-2b6f62688e3c
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Pharbest Pharmaceuticals, Inc.
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2006-01-10
- Substance
- ACETAMINOPHEN
- Active strength
- 500 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 16103-376-08 | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 16103-376-11 | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 16103-376-06 | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 16103-376-08 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 16103-376-11 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 16103-376-06 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 16103-376-08 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 16103-376-11 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 16103-376-06 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded product | product | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… | |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 16103-376-08 | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 16103-376-06 | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 16103-376-11 | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pharbetol
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 04dbd98f-c74d-43b2-8bda-74f18be7cf6c | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 16103-376-06 | 2024-01-19 | Pharbetol Extra Stength Tablet |
| 16103-376-08 | 2024-01-19 | Pharbetol Extra Stength Tablet |
| 16103-376-11 | 2024-01-19 | Pharbetol Extra Stength Tablet |
| 16103-376-06 | 2022-01-28 | Pharbetol Extra Stength Tablet |
| 16103-376-08 | 2022-01-28 | Pharbetol Extra Stength Tablet |
| 16103-376-11 | 2022-01-28 | Pharbetol Extra Stength Tablet |
| 16103-376-06 | 2020-05-22 | Pharbetol Extra Stength Tablet |
| 16103-376-08 | 2020-05-22 | Pharbetol Extra Stength Tablet |
| 16103-376-11 | 2020-05-22 | Pharbetol Extra Stength Tablet |
| 16103-376-06 | 2020-01-31 | Pharbetol Extra Stength Tablet |
| 16103-376-08 | 2020-01-31 | Pharbetol Extra Stength Tablet |
| 16103-376-11 | 2020-01-31 | Pharbetol Extra Stength Tablet |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16103-376-06 | Pharbetol | 50 in 1 BOTTLE, PLASTIC | TABLET | 50 | 5 | |
| 16103-376-06 | Pharbetol | 1 in 1 CARTON | TABLET | 1 | 5 | |
| 16103-376-08 | Pharbetol | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 5 | |
| 16103-376-08 | Pharbetol | 1 in 1 CARTON | TABLET | 1 | 5 | |
| 16103-376-11 | Pharbetol | 1000 in 1 BOTTLE, PLASTIC | TABLET | 1000 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16103-376-06 | EA - Each | 16103-376 | b0ec28db-7535-413e-805f-e1416eeca918 | 1 | 2012-07-24 |
| 16103-376-08 | EA - Each | 16103-376 | b9284189-e1cd-4f69-88be-fb02466b57ca | 1 | 2012-07-24 |
| 16103-376-11 | EA - Each | 16103-376 | 7d6a6a6a-b98e-44d2-8664-e2351539d62b | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ACETAMINOPHEN | ACTIVE INGREDIENT | 362O9ITL9D | PHARBETOL (ACETAMINOPHEN) TABLET [PHARBEST PHARMACEUTICALS, INC.] | 1 | |
| ACETAMINOPHEN | ACTIVE MOIETY | 362O9ITL9D | PHARBETOL (ACETAMINOPHEN) TABLET [PHARBEST PHARMACEUTICALS, INC.] | 1 | |
| POVIDONE K30 | INACTIVE INGREDIENT | U725QWY32X | PHARBETOL (ACETAMINOPHEN) TABLET [PHARBEST PHARMACEUTICALS, INC.] | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | PHARBETOL (ACETAMINOPHEN) TABLET [PHARBEST PHARMACEUTICALS, INC.] | 1 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | PHARBETOL (ACETAMINOPHEN) TABLET [PHARBEST PHARMACEUTICALS, INC.] | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | PHARBETOL (ACETAMINOPHEN) TABLET [PHARBEST PHARMACEUTICALS, INC.] | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 16103-376-06 | 16103037606 | 1 BOTTLE, PLASTIC in 1 CARTON (16103-376-06) / 50 TABLET in 1 BOTTLE, PLASTIC | 2006-01-10 | 0000-00-00 | No | No | Current | |
| 16103-376-08 | 16103037608 | 1 BOTTLE, PLASTIC in 1 CARTON (16103-376-08) / 100 TABLET in 1 BOTTLE, PLASTIC | 2006-01-10 | 0000-00-00 | No | No | Current | |
| 16103-376-11 | 16103037611 | 1000 TABLET in 1 BOTTLE, PLASTIC (16103-376-11) | 1000 tablet | 2006-01-10 | 0000-00-00 | No | No | Current |